Overview

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Multiple-dose, double-blind, double-dummy, parallel, randomized, placebo and active controlled study of pharmacokinetics of Diractin® as well as safety and efficacy for muscle soreness from exercise.
Phase:
Phase 2
Details
Lead Sponsor:
IDEA AG